Historic settlement for over 1,300 survivors of clergy and adult abuse within the Roman Catholic Archdiocese of Los Angeles, marking a pivotal moment for justice.
October 29, 2025
Waters Kraus Paul & Siegel is proud to share that seven trial lawyers have been selected in the Texas and California editions of the Super Lawyers and Rising Stars legal guides. The honors reflect the team’s deep expertise in litigation on behalf of plaintiffs and the respect they have earned among peers.
Super Lawyers is one of the most respected legal industry guides, with a selection process that begins with peer nominations and continues through independent research and blue-ribbon panel review. Fewer than 5 percent of attorneys in Texas are chosen each year, making this honor a reflection of the firm’s standing within the legal community.
The 2025 Super Lawyers honorees include:
In addition, the following firm attorneys have been named to the Super Lawyers Rising Stars guide, which is designed to recognize early and mid-career attorneys.
For more details, visit the Super Lawyers website.
About Waters Kraus Paul & Siegel
Waters Kraus Paul & Siegel is a national plaintiffs’ law firm devoted to helping families in personal injury and wrongful death cases involving asbestos and mesothelioma, benzene exposure, dangerous pharmaceuticals, medical devices, and birth defects caused by pesticides, toxic chemicals, opioid use, and semiconductor chip manufacturing. The law firm also represents plaintiffs in qui tam whistleblower matters and cases that uncover false claims submitted to the government. Based in Dallas, Texas, with offices in Los Angeles, California, and Moline, Illinois, Waters Kraus Paul & Siegel has represented families from all fifty states and many foreign countries, as well as foreign governments.
Our Results
Historic settlement for over 1,300 survivors of clergy and adult abuse within the Roman Catholic Archdiocese of Los Angeles, marking a pivotal moment for justice.
A Philadelphia jury awarded a record verdict against ExxonMobil for failing to warn about cancer risks due to benzene in its petroleum products.
Private equity firm and co-defendants agree to pay $25M in Medicaid fraud case alleging mental health services provided by unqualified providers.